Myungin Nalcalisin Tablet 50 mg (Benzbromarone)

Adult dose

1. Gout Adults: Administer 25 mg or 50 mg of benzbromarone orally once daily, followed by a maintenance dose of 50 mg of this drug 1 ∼ 3 times daily. 2. Hypertension accompanied by hyperuricemia Adults: Administer 50 mg of this drug orally 1 ∼ 3 times daily. Adjust the dose appropriately according to symptoms.

This medication can cause severe liver problems within six months of starting treatment; therefore, regular liver function tests should be conducted during this period. If there are signs of liver dysfunction or jaundice, discontinue use immediately and seek appropriate treatment. It is very important to confirm normal liver function before taking this medication. This drug should not be used by individuals with hypersensitivity, kidney stones, renal impairment, pregnant women, those who may become pregnant, or patients with liver disease. Allergy reactions such as skin rashes, itching, and facial flushing may occur; if such symptoms arise, stop taking the medication immediately. Gastrointestinal discomfort, diarrhea, abdominal pain, and nausea may occur, and in rare cases, headaches, conjunctivitis, and edema may also occur. Caution is especially needed for patients with hypertension as adverse reactions may be more pronounced. Do not initiate use of this drug during acute gout flare-ups and it is recommended to take other medications in conjunction to prevent flare-ups during the initial phase of treatment. Patients prone to uric acid stones should maintain sufficient water intake to increase urine volume and keep urine alkaline. Since this drug can interact with other medications, it is advisable to consult a specialist, especially when taking allopurinol, anticoagulants, anti-tuberculosis drugs, and aspirin together. It is safer for pregnant or nursing women to avoid this medication, and if necessary, breastfeeding should be avoided. Safety has not been established for children, and the elderly may require dosage adjustments due to decreased physical function. Keep this medication out of reach of children and do not transfer it to another container to maintain its quality. Long-term use of this medication in high doses has been reported to increase the risk of hepatocellular carcinoma, so caution is needed with prolonged use.

• Photosensitivity reactions
• itching
• hives
• rash
• facial flushing
• erythema
• acute severe hepatitis
• jaundice
• elevated AST
• elevated ALT

This medication is sensitive to light, so it should be stored in a container that does not allow light in and kept in a cool, room temperature environment. Avoid direct sunlight and do not place it in extremely hot or cold areas.

Appearance

White round tablet.

Package unit

30 tablets/bottle, 100 tablets/bottle